FEMS is leading the way in promoting excellence and diversity in science, and in channelling high quality knowledge to solving today’s societal problems around microbiology. It does this by funding research, publishing journals, connecting microbiologists and partnering with other organizations.
Our main goals are to benefit microbiology in Europe and across the world through research, networking, education and outreach; and to help our Member Societies serve the microbiology community.
To achieve these we provide opportunities in networking, research and communication, as well as developing revenue streams to maintain and develop our charitable activities.
Our organizational direction 2015 – 2019 is summarized in our strategic framework.
Microorganisms play an essential role in humans, animals, plants, the environment and industrial processes, and impact significantly on health, the economy, food supply, and ecosystems. Scientific knowledge of microorganisms and their interactions in the biosphere is essential for informed decision and policy making, improved health and well-being, wealth generation and environmental quality and sustainability. FEMS’ vision is to coordinate and lead the acquisition of scientific knowledge and innovation in microbiology and to maximise communication of this knowledge, and its importance, to scientists, politicians, policy makers, industry and the general public.
FEMS aims at advancing microbiology in Europe and the neighbouring regions through grants, publication of internationally renowned journals, news items, congresses, teaching support, and additional initiatives that fulfil its Vision.
In our drive to streamline best practices, we have enacted policies that underpin the way FEMS as an organization does its work and interacts with its staff, the wider microbiological community and the world.
Equal Opportunities Policy – people should be treated with dignity and respect, with value being placed on ensuring diversity is reflected in our organization
Anti-Bullying and Harassment Policy – bullying and harassment of any kind is not tolerated
The investigation of novel approaches for tackling the antimicrobial resistance crisis must be part of any global response to this problem if an untimely reversion to the pre-penicillin era of medicine is to be avoided. One such promising avenue of research involves so-called antibiotic resistance breakers (ARBs), capable of re-sensitising resistant bacteria to antibiotics. This review introduces the area of ARB research, summarises the current state of ARB development with emphasis on the various major classes of ARBs currently being investigated and their modes of action, and offers a perspective on the future direction of the field.